AnaPath, is a global company including contract research organization (CRO) and pathology services that provides R &D services in the preclinical and bioanalytical fields. AnaPath is formed by two main sections: AnaPath Services, based in Switzerland and focused on pathology, and AnaPath Research, based on Barcelona and focused in preclinical development. AnaPath Services emanates from RCC/Harlan and was established in 2013. It is located close to the pharmaceutical capital Basel and has a surprisingly wide experience for a young company due to company due to its history. AnaPath Services is recognized for the scientific competence in toxicologic pathology, high operational speed and reliability. The current AnaPath Research was Founded in 1980, as CIDASAL, the site had been part of multiple international companies such as RCC, Harlan and Envigo , always providing high quality services to our sponsors. In the late 2019, AnaPath services acquire the site and started a journey to the excellence of research. AnaPath is structured in departments according to the field of the services we offer, and in perfect coordination. General Toxicology performs a full range of studies to support the pharmaceutical, chemical, agrochemical and veterinary industries. The studies are performed to fulfill global regulatory guidelines in accordance with GLP (Good Laboratory Practices).